- Research
- Medical & Pharmacological
- GI Symptom Management
Does treating GI symptoms help autistic children’s behavior?
Treating constipation, reflux, and GI pain is standard pediatric care — do it regardless. Whether it also eases irritability and challenging behavior is promising, but far from settled.
Podcast·Two-voice deep dive
Listen to the discussion
Chapters & transcript
This is an AI-generated discussion of this article, transcribed automatically. The written summary below is the reviewed source — if the two differ, go by the summary.
0:00What is this discussion about?
Host A So imagine your car's check engine light comes on, right? And it just starts blaring this like piercing inescapable warning alarm.
Host B Yeah, that sounds incredibly stressful.
Host A Right. It is. Now imagine your mechanic solution is to just, you know, reach under the dashboard and snip the wire to the speaker so you don't have to hear it anymore.
Host B Oh, wow. Yeah, that's completely absurd.
Host A It sounds like a joke, but I mean, for decades, that is essentially how a lot of the medical field unintentionally treated autistic children who were experiencing severe gut pain.
Host B It's a brutal analogy, I know, but it really perfectly captures that historical disconnect. We looked at the outward alarm, right, the behavioral distress, and we basically just tried to turn it off rather than looking under the hood to see what was actually physically broken.
Host A Which is exactly our mission for this deep dive. Today, we are custom tailoring our focus for you to really unpack the research on gastrointestinal or GI symptom management, specifically for autistic children. We're going to look at the evaluation and treatment of issues like, you know, constipation, reflux, diarrhea, and severe abdominal pain.
Host B And we're pulling this analysis from a very specific stack of sources for you. We're looking at systematic reviews and meta-analyses that track how prevalent these issues are alongside some clinical consensus algorithms.
Host A Right.
Host B We've also got some observational association studies and a handful of, like, small randomized controlled trials, RCPs.
Host A But real quick, before we jump in, I need to state plainly that this deep dive is just a summary of research findings. It is not medical advice and absolutely nothing discussed here is a recommendation for any individual child.
Host B Yeah, that's a crucial baseline to set. We are simply unpacking what the data actually says, how researchers gathered it, and well, maybe most importantly, where the massive gaps in the science still live.
1:53What does 'GI symptom management' actually mean here?
Host A So let's start with the intervention itself. When the sources talk about, quote, GI symptom management in this context, what are they actually describing? Because on the surface, it sounds like we might just be talking about, I don't know, normal pediatric care.
Host B Well, that's exactly what it is. The treatment we're discussing involves standard foundational pediatric GI care delivered by pediatricians and their clinical teams.
Host A Okay, so nothing wild.
Host B No, not at all. It usually starts with fundamental lifestyle adjustments. You know, tweaking dietary fiber, increasing fluids, and establishing highly predictable toileting routines to reduce any anxiety around the bathroom.
Host A But when lifestyle tweaks aren't enough, we move into medications, right? Because the sources frequently mention osmotic laxatives like PEG or polyethylene glycol, along with standard medications for reflux.
Host B Yeah, they do.
Host A Now, for those of us who aren't medical professionals, how does an osmotic laxative actually work compared to like those harsh stimulant laxatives you might buy over the counter?
Host B So think of an osmotic laxative like a sponge.
Host A A sponge.
Host B Right. Instead of using chemicals to artificially stimulate the bowel muscles to cramp and push, which, you know, can be incredibly painful.
Host A Oh, yeah, definitely.
Host B The osmotic laxative simply draws water into the colon. It acts like a sponge soaking up surrounding moisture to just soften everything naturally.
Host A Oh, okay.
Host B This makes the physical process of going to the bathroom much easier and, frankly, way less traumatic for the child.
Host A That makes a lot of sense, especially for a child who might already have heightened sensory sensitivities. And the sources note that sometimes microbiome, prebiotic, or probiotic supplements get grouped into this intervention space as well. We will definitely need to untangle that later. Yeah, it gets messy. But regarding the intensity and duration of these treatments, how long are kids on this stuff?
Host B Well, there is no distinct special autism protocol for duration. The intensity and timeline completely depend on the specific symptom and are dictated entirely by general pediatric guidelines.
Host A Oh, I see.
Host B Yeah, so if a child has chronic reflux, they get treated based on the standard medical practices for any child with chronic reflux.
4:02Does treating the gut also fix behavior?
Host A Okay, but here is where the core debate seems to happen in the research. The primary claim of this intervention is obvious. It aims to relieve physical GI symptoms.
Host B Right.
Host A Improving stool frequency, stopping the agonizing abdominal pain. But there is a secondary claim in the research, which is that treating these physical gut issues will significantly reduce behavioral symptoms. Yes. Things like irritability, challenging behavior and severe distress.
Host B And that secondary claim is really the entire pivot point of this field of research.
Host A Returning to that car analogy for a second, this intervention claims that the behavioral distress is just the beeping alarm.
Host B Correct.
Host A It's arguing that to stop the beeping, we shouldn't just be throwing behavioral therapies at the child. We actually need to fix the engine. We have to treat the gut.
Host B It's a really compelling framework. But to understand how the medical community arrived at this whole check the engine approach, we kind of have to look at how this specific evidence base developed. Because this research didn't just appear overnight. You know, it grew out of a collision between two very different fields, general pediatrics and autism specific clinical observation.
Host A So how did that collision actually happen? Did pediatricians just suddenly start noticing a trend or?
Host B Well, it began with clinicians in the trenches realizing that the standard playbook just wasn't working. The sources point to a landmark 2010 consensus report by Bowie and colleagues and a 2012 algorithm for managing constipation by Furuta and colleagues. These were essentially leading experts gathering in a room and saying, hey. We have a massive blind spot here.
Host A Wow.
Host B Yeah. They recognized that autistic kids were experiencing profound GI distress, but it was being widely missed or mischaracterized. They had to formally adapt general pediatric guidelines just to get practitioners to pay attention to the physical health of these patients.
Host A I'm assuming that once those consensus reports were published, it kind of triggered a wave of researchers wanting to actually measure the scope of the problem.
Host B Exactly. It sparked a massive shift into large-scale observational studies and systematic reviews. The goal was to figure out just how widespread these gut problems were compared to the neurotypical population.
Host A Right. Getting the numbers.
Host B Yeah. And we see this in a major meta-analysis from McEllenon and colleagues in 2014 and an even larger systematic review published in Frontiers in 2023. Okay. And independent teams have repeatedly replicated these findings. The high prevalence of GI issues in this population is arguably one of the most well-documented phenomena in autism research.
Host A But I mean, observing that a problem exists doesn't automatically prove that treating it cures the behavioral symptoms.
Host B No, not at all.
Host A Proving the scope of the gut pain is entirely different from proving that the gut pain is actually causing the behavioral alarm.
Host B That is the crucial scientific hurdle. To test what researchers call the treatment arrow. Basically, the hypothesis that treating the gut directly improves the behavior the study designs had to fundamentally change.
Host A Because you can't just observe it.
Host B Right. You can't use an observational study for that. You have to use clinical trials. Yeah. So researchers moved to small, randomized, controlled trials, like a double-blind RCT by Sanctuary and colleagues, alongside various unblinded dietary studies.
Host A Okay. But I noticed our sources flag a pretty significant complication here regarding those treatment studies.
Host B Yeah.
Host A Much of the evidence trying to prove this treatment to behavior arrow is heavily tangled up with those microbiome and probiotic supplements we mentioned earlier.
Host B It is a massive confounding variable. Probiotic research is its own highly complex, you know, strain specific field. Right. When studies test probiotic supplements instead of standard osmotic laxatives, they're essentially testing gut bacterial alterations.
Host A Which is a whole different ballgame.
Host B Exactly. That might have its own distinct neurological effects through the gut brain axis. It completely muddies the waters, making it incredibly difficult to isolate the behavioral effect of just standard basic GI care.
8:04How well can these studies actually test that claim?
Host A So if the methodology is that tangled, we need to look really closely at what these studies actually measured and, well, who was participating in them. If you line up these different types of studies side by side, how do the participant pools compare?
Host B The disparity in sample sizes is, frankly, staggering. I mean, the population studied was consistently autistic children presenting with GI symptoms. But the scale of the studies is just night and day.
Host A Give me the numbers. What are we talking about here?
Host B Okay, so look at the prevalence meta-analysis by McKellenan. They aggregated data from 2,215 children across 15 different studies.
Host A Wow. Okay, so over 2,000 kids.
Host B Yes. That gives you a highly robust, statistically powerful look at how common these issues are.
Host A There's always but.
Host B When you look at the studies attempting to test the actual treatment arrow, like that double-blind RCT by sanctuary, looking at whether a specific intervention improved behavior, the sample size was eight children.
Host A Wait, I have to stop you there. Eight children total in a trial trying to prove a major clinical intervention.
Host B Eight children.
Host A Like a single digit.
Host B Eight. Total in the whole trial.
Host A I am struggling to see how anyone can draw a definitive, generalized scientific conclusion from a sample size of eight, especially when compared to a prevalent study of over 2000. That is practically a pilot study.
Host B It really is.
Host A What specific outcome measures were they even tracking for those kids?
Host B Well, they split their measurements into two categories. The first were gut outcomes tracking the physical prevalence and severity of constipation, diarrhea, or self-reported abdominal pain.
Host A Okay, that makes sense.
Host B And the second category focused on behavioral outcomes. They used standardized clinical scales to measure changes in irritability. social withdrawal, stereotypy, which involves repetitive movements, hyperactivity, and sometimes language regression.
Host A But measuring gut outcomes seems pretty straightforward, right? Did the child have a bowel movement? Yes or no. But measuring irritability or withdrawal is highly subjective. How long were they actually watching these kids to see if the behavior changed?
Host B The timeframes were generally quite short. For instance, the unblinded diet study mentioned in the sources relied on parent report checklists of behavior taken just before the intervention and then again after a relatively brief set period.
Host A So no long-term check-ins?
Host B No, the sources do not highlight long-term follow-ups. We were really only looking at short-term snapshots of behavior change, not longitudinal data.
10:32How common are GI problems in autistic children?
Host A Man, okay, let's get into the core data then. When you synthesize all of these different studies, what do the findings actually show?
Host B We basically need to mentally separate the hard numbers into two distinct buckets to make sense of the landscape. Association findings and treatment findings.
Host A Association being the studies just looking at how common the GI issues are in the autistic population.
Host B Correct. And in that bucket, the findings are incredibly strong and highly consistent. The 2023 Frontiers Systematic Review concluded that roughly 55% of autistic children experience some form of GI symptom.
Host A Over half the population.
Host B Over half. And they measured this using odds ratios, which compare the likelihood of an autistic child having these symptoms against a child with typical development.
Host A Okay, what are the ratios?
Host B The odds ratio for constipation is 3.86. For diarrhea, it's 3.63. For abdominal pain, it's 2.45.
Host A So an odds ratio of 3.86 means an autistic child is nearly four times more likely to experience severe constipation than a neurotypical peer.
Host B Yes.
Host A That is a massive flashing red light. That isn't a subtle correlation. It's a foundational reality for a huge portion of this population.
Host B It is absolutely undeniable. But when we transition to the second bucket, the treatment findings, where we test if treating that gut issue actually reduces the behavioral distress, the ground gets very, very shaky.
Host A But the numbers must look good on paper, right? Otherwise, this wouldn't be such a prominent theory.
Host B Well, the numbers are technically positive, but looking at the actual study designs, it feels like a bit of a gut punch. That sanctuary trial with the eight children, it did report a drop in irritability, specifically a decrease of negative 6.5 points on their scale. Okay. And the unblinded diet study showed behavior scores improving from an average of 80.03 down to 75.82, which, you know, crossed the threshold for statistical significance.
Host A So the numbers moved in the right direction. The measurable distress went down.
12:35Why are GI problems so much worse in this population?
Host A But why are these GI symptoms so uniquely severe and difficult to manage in this specific population in the first place? Like, does the research attribute this just to biology or is there a behavioral component to the gut issues themselves?
Host B The sources are very clear that it is highly intertwined with specific autistic traits. They explicitly attribute a lot of the severe chronic constipation to selective eating and profound sensory issues.
Host A Break that down for me. How does a sensory issue create a gut problem?
Host B Okay, so imagine a child with intense sensory aversions to textures. They might physically gag the feeling of fruit or vegetables.
Host A Right.
Host B So their diet becomes highly restricted to, quote, safe foods often process starches, crackers, or bread.
Host A Yeah, that's really common.
Host B Now, if a child is consuming zero dietary fiber and avoiding water... That creates a physical situation in the gut that is almost like concrete.
Host A Oh, wow.
Host B It creates a vicious cycle. The sensory aversion dictates the diet. The diet causes severe constipation. The constipation causes agonizing pain, and the pain amplifies the behavioral distress.
Host A That sounds awful.
Host B It is. Standard management is incredibly difficult when you can't just tell the child to eat an apple.
Host A That paints a really vivid, difficult picture. So we have incredibly strong association data, but the treatment data relies on a sample size of eight and unaligned dietary surveys. What do the sources say about the overall strength of this evidence?
14:00What are the weaknesses in this evidence?
Host A Where are the cracks in the foundation?
Host B The sources themselves are deeply critical of the limitations. The first major flaw they detail is a fundamental design question mismatch.
Host A Meaning researchers are asking a question that their study design isn't actually built to answer.
Host B Exactly. People in the field frequently cite massive prevalence and association reviews, like the one with over 2,000 kids, as proof that treating the gut will cure the behavior.
Host A Ah, I see.
Host B But the sources explicitly warn against this. A strong association, even an odds ratio of nearly 4, is not proof of treatment efficacy.
Host A It's like assuming that because carrying an umbrella and wearing rain boots always happen together, the rain boots must be causing the umbrella. You're completely missing the external factor, the rainstorm, which in this medical context is the underlying neurodevelopmental condition itself. You can take away the rain boots, but it doesn't stop the storm.
Host B That is a perfect way to look at it. You just cannot use association data to prove a cure. The sources also heavily flagged design weaknesses, the behavior improvement studies. They suffer massively from an expectancy stack.
Host A An expectancy stack. I would assume that means placebo effect, but like by proxy because these are unblinded and parent reported.
Host B That is the exact mechanism.
Host A Yeah.
Host B Imagine you're a parent desperate to help your child who's in distress. You put them on a difficult, highly restrictive diet or a new treatment regimen.
Host A Right. You're putting in a lot of effort.
Host B Exactly. And at the end of the month, you are the one filling out the subjective checklist asking, is their behavior better? The psychological pressure is immense. You expect it to work. You need it to work. Of course. So you consciously or subconsciously grade them on a curve. Because the researchers didn't use blinded independent observers, the risk of bias completely undermines the data.
Host A That is completely understandable from a human perspective, but disastrous from a scientific one.
Host B Really disastrous, yeah.
15:56Can GI pain get mistaken for 'just autism' behavior?
Host A What about the relationship between the behavior and the gut pain itself? Because the sources mention bidirectionality.
Host B This is perhaps the most tragic limitation in the research. We call it bidirectionality or reverse causation. The sources note that while GI pain definitively drives challenging behavior, the behavior itself actually masks the clinical recognition of the GI pain.
Host A Hold on, I want to make sure I understand the mechanics of that. The alarm is so loud that the mechanic forgets to look at the engine.
Host B Essentially, yes. Imagine a child who is non-speaking or who struggles with interoceptive awareness, meaning their brain has trouble processing or locating internal physical sensations.
Host A Okay.
Host B They feel an agonizing cramp in their stomach. but they don't have the language or the bodily awareness to point to their belly and say, it hurts here. Instead, they react to the overwhelming pain by hitting their head, screaming, or completely withdrawing.
Host A And a clinician looks at that external reaction and says, oh, that's an autistic meltdown. That's just part of the diagnosis.
Host B Exactly. And the stomachache goes completely undiagnosed. The outward behavior masks the internal gut issue, while the gut issue is the very thing causing the behavior. It is a closed loop of misinterpretation that leaves the child in physical agony.
Host A That is deeply frustrating. It's a communication barrier that physically harms the patient. And it leads to a huge gap in the actual science. You mentioned earlier that standard of care treatments are extrapolated from general pediatrics. What are the open questions here? What does the evidence not answer?
Host B The gaping hole in the science is the lack of large, adequately powered, blinded, randomized controlled trials testing standard GI treatments and measuring behavioral outcomes.
Host A So we have trials for complex probiotics and, you know, unlined dietary surveys, but nobody has done a rigorous large-scale trial where they just give kids a standard osmotic laxative to relieve the physical pressure and see if the irritability scores drop.
Host B Yeah, it is exactly the gap. We know definitively that treating the gut helps the gut. The medical science on relieving constipation is sound, but the direct, isolated scientific arrow proving that standard, basic GI treatment leads to behavioral improvement remains vastly under-tested in this specific population.
18:10How does a doctor decide what to do right now?
Host A But if the behavioral evidence is that weak and full of holes, how does a doctor in an exam room actually make a decision? I mean, they can't wait a decade for a 500-person RCT to get published while a child is sitting in front of them in distress.
Host B No, they can't. Clinicians navigate this using a concept called diagnostic overshadowing. They're evaluating the harm of omission, the cost of doing nothing.
Host A Expanding on that, the harm of writing everything off is just autism.
Host B Precisely. Clinicians evaluate the situation through a causal aggravator classification. The GI issue is an autism.
Host A Right.
Host B Constipation is an entirely separate, highly common physical comorbidity that heavily aggravates the child's overall distress.
Host A So the reasoning process for a pediatrician is basically a risk-benefit analysis of undertreatment.
Host B Yes. They weigh the immense harm of leaving a child in physical pain. If a clinician assumes the irritability is purely neurological and ignores the digestive system, they are engaging in diagnostic overshadowing. They are missing a painful, highly fixable standard of care medical problem.
Host A Because implementing a gentle osmotic laxative or adjusting fluids is incredibly low risk medicine.
Host B It is fundamental pediatrics. Therefore, clinicians lean entirely on general pediatric guidelines. They treat the gut aggressively and appropriately, first and foremost, simply because it is the humane standard medical care for physical pain.
Host A Right.
Host B They view any resulting behavioral improvement as a promising, though scientifically less proven, bonus. You treat the pain because the patient is in pain. Full stop.
Host A That brings a tremendous amount of clarity to a very messy pile of research. It separates the guaranteed physical necessity from the hopeful behavioral outcome.
19:54What are the key takeaways?
Host A So if you're taking notes on this deep dive, what are the core takeaways? We have four specific findings from the sources for you to recap.
Host B First, the association is real. GI problems, particularly constipation, are roughly three to four times more common in autistic children than in their neurotypical peers.
Host A Second, easing that physical pain through standard pediatric care like fiber, fluids, and osmotic laxatives is strongly supported to treat the gut issue itself. It is simply good, necessary medicine.
Host B Third is the major limitation. The claim that treating the gut will drastically improve behavioral symptoms relies, currently, on very small, mostly unblinded studies or research heavily focused on probiotic supplements rather than standard care.
Host A And fourth, the glaring open question. Science still desperately needs large double-blind trials to determine if standard laxative and fluid protocols actually directly reduce irritability in autistic populations.
Host B The field has proven the scope of the problem. It hasn't yet proven the behavioral cure.
Host A Before we close, a reminder that decisions about any individual child belong in a conversation with that child's pediatrician or care team, and that this episode cannot make that call. Note that research on this topic continues and that Spectrum Connect will update its coverage as new evidence appears.
Host B Spectrum Connect translates autism research into plain language for parents and checks findings for accuracy against misinformation. If you are a credentialed expert, MD, PhD, PsyD, or DO, and would like to help validate our findings, email research at spectrumconnect.us.
Host A We started today talking about a car alarm and the historical tendency to try and shut off the noise without looking at the engine. It forces us to reconsider how we interpret communication, which leaves us with a final thought to ponder.
Host B If a child's external behavior is actually their primary or even only language for internal physical pain, how much of what the medical community historically labeled as autistic behavior was actually just a completely human response to an undiagnosed stomachache?
Please know this. If your child suddenly becomes more irritable, aggressive, or withdrawn, it’s easy — for anyone, including clinicians — to write it off as “just autism.” A real, common cause is untreated GI pain: autistic children often can’t easily tell you their stomach hurts. Ruling out constipation, reflux, or other GI problems first is standard, low-risk pediatric practice, not a fringe idea.
Key Takeaways
GI problems are common in autism — about half of autistic children have a GI symptom, and rates of constipation, reflux, and abdominal pain run roughly 2.5–4 times higher than in non-autistic children.
Treating GI symptoms is standard, low-risk pediatric care — fluids, fiber, toileting routines, osmotic laxatives, and reflux management are evidence-based in general pediatrics. Do this regardless of what it does for behavior.
Don’t expect it to reliably fix behavior — the idea that treating GI pain calms irritability and meltdowns is plausible and clinically sensible, but direct evidence is thin: small trials, often unblinded, some overlapping with probiotic research.
Sudden irritability, self-injury, or withdrawal can be a pain signal, not just “autism behavior” — get GI symptoms checked before assuming a behavior change is purely behavioral.
What this means for you
GI symptom management means evaluating and treating constipation, reflux, diarrhea, and abdominal pain the way any pediatrician would — because autistic children get these problems more often, not because it’s a special autism therapy. Consensus pediatric guidance recommends treating them per standard-of-care: fluids and fiber, toileting routines, osmotic laxatives like PEG for constipation, and reflux management.
Here’s where two different questions get tangled together. The first — should GI symptoms be treated? — has a near-certain yes; it’s standard care, low-risk, and follows general pediatrics. The second — will treating GI symptoms also improve irritability, meltdowns, or other challenging behavior? — is genuinely uncertain. The GI–behavior link is real and consistent (autistic children with more GI symptoms tend to show more irritability and distress), but that’s an association, not proof that treating the gut changes the behavior. The handful of trials that test the treatment side directly are small, often unblinded, and sometimes overlap with probiotic/microbiome research, which we review separately since those effects are strain-specific.
Who was studied. The prevalence figures come from a meta-analysis of 15 studies (2,215 children) and a PROSPERO-registered systematic review; the treatment-arrow evidence comes from small trials, including one double-blind pilot with just 8 children.
Where the studies landed
Two different questions, two different kinds of evidenceWhether to treat GI symptoms, and whether treating them changes behavior, are separate questions with separate evidence.
3 GI symptoms & treating them: well-documented, standard care
2 Does treating it also help behavior: promising but thin
Tap any tile to read it.
GI symptoms & treating them: well-documented, standard care3
Does treating it also help behavior: promising but thin2
Spectrum Connect reviews published research on interventions parents are exploring for their autistic children — so you can see where the evidence actually stands. No agenda, no selling, no cherry-picking. Just the studies, our method, and what it means for you.
See the research behind this
For anyone who wants to check our work · 5 sources
Where we looked
This run was a scoping search only — done via general web search (2 searches: GI-symptom prevalence/association/treatment guidelines, and the treatment-arrow question of whether treating GI symptoms improves behavior), not the reproducible Boolean search of record and not the PubMed/Epistemonikos API layer we use on a fully conformant run. That means we can't publish reproducible per-database counts or a formal PRISMA flow for this run. Below is the search string a full conformant pass would run against MEDLINE (PubMed), Embase, PsycINFO, CENTRAL (Cochrane), CINAHL, and Epistemonikos — we haven't executed it against the database APIs yet.
("autism"[MeSH] OR autis*[tiab] OR ASD[tiab]) AND (gastrointestinal[tiab] OR constipation[tiab] OR "GI symptom*"[tiab] OR reflux[tiab] OR "abdominal pain"[tiab]) AND (treat*[tiab] OR manage*[tiab] OR laxative[tiab] OR behavior*[tiab] OR irritab*[tiab] OR random*[tiab])
Run on PubMed →
What we did with what we found
What the strongest evidence says
Consistently high — constipation, reflux, and abdominal pain are 2.5–4× more common in autistic children, and GI symptoms track with irritability and distress.
Follows established general-pediatrics guidelines — fluids, fiber, toileting routines, osmotic laxatives. ASD-specific trials are sparse, so this is extrapolated, evidence-based standard care.
A promising signal from a handful of small, often unblinded or microbiome-mediated trials — not yet established as a reliable effect.
Keep reading
What would you like to do?
Want to talk to a parent who’s been there?
We match you with families whose kid is like yours. Free, takes two minutes.
Heard of something we haven’t covered?Suggest an article
If another parent, a clinic or a video mentioned a therapy you can’t find here, tell us. We’ll read the research and review it next.
Suggest an articleThink we got something wrong?Report a factual error
We publish the whole record so it can be checked, and that only counts if we act on what you find. If a number looks wrong, a study is missing or has been retracted, or we’ve read a finding in a way the evidence doesn’t support, tell us.
You don’t need a research background to file one. “This doesn’t match what our doctor told us” is a useful report. Every one reaches a person: we reply within seven days, and within thirty we have either corrected the page or told you when we will. Substantive reports send the affected steps back through the protocol and need fresh sign-off before anything here changes.
Report a factual errorAre you a clinician or researcher?Review this article
If you have read this and the evidence holds up, you can sign off on it. We send you a personal review link where you confirm your credentials, and our team checks every review before anything is published. Once approved, your name and a link to your profile appear on this article.
Ask to review this